Docetaxel
Chemical Name: [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxy-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester benzenepropanoic acid
Purity: ≥99%
Biological Activity
Binds and stabilizes microtubules; leads to cell cycle arrest and apoptosis. Displays significant antitumor activity in ovarian and gastric tumors. Prevents microtubule depolymerization and disassembly in the absence of GTP. Exhibits cytotoxic activity.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Docetaxel: a review of its use in metastatic breast cancer.
Lyseng-Williamson and Fenton
Drugs, 2005;65:2513 -
Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors.
Ramaswamy and Puhalla
Drugs Today (Barc), 2006;42:265
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for Docetaxel
The citations listed below are publications that use Tocris products. Selected citations for Docetaxel include:
10 Citations: Showing 1 - 10
-
Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer.
Authors: Bonifacio Nicolás Et al.
Int J Biol Sci 2023;19:1731-1747
-
Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer.
Authors: Geoffrey Et al.
Cancer Rep (Hoboken) 2020;3:e1284
-
CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death.
Authors: Leslie V Et al.
Cancer Cell Int 2019;19:26
-
Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.
Authors: Mabe Et al.
J Clin Invest 2018;128:4413
-
Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer.
Authors: Hui Et al.
Oncotarget 2017;8:103744-103757
-
A high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues.
Authors: Malin Et al.
Sci Rep 2017;7:6600
-
The BTK Inhibitor, Ibrutinib (PCI-32765) Overcomes PacT. Resistance in ABCB1 and ABCC10 Overexpressing Cells and Tumors.
Authors: Zhang
Mol Cancer Ther 2017;16(6):1021
-
Antitumor activity of amidino-substituted benzimidazole and benzimidazo[1,2-a]quinoline derivatives tested in 2D and 3D cell culture systems.
Authors: Karmen Et al.
J Enzyme Inhib Med Chem 2016;31:1139-45
-
The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated PacT. resistance: a preclinical and pharmacokinetic study.
Authors: Kathawala Et al.
Oncotarget 2015;6:510
-
Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated PacT. resistance: a preclinical study.
Authors: Kathawala Et al.
Mol Cancer Ther 2014;13:714
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Docetaxel
Average Rating: 5 (Based on 1 Review)
Have you used Docetaxel?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
Used as a control to induced apoptosis in cancer cell lines